Activity value 66united states Buyer&Supplier,Last transaction date:
2022-07-18Address: 296 cambridge science park , milton road , cambridge
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shire human genetic therapies ltd. from 2021 to 2022.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2022, the company has completed 64 transactions, with a transaction quantity of 1472 and a transaction weight of 575814.
YearTransactionsQuantityWeight
202149235998
2022641472575814
Bill of lading data
<
1/15
>
Trade date
2022/07/18
B/L No.
zimugoa1044644
Suppliers
takeda pharma international ireland branch
Buyers
shire human genetic therapies ltd.
4audifarma s.a.
colombiabuyer,they trade on 2013-11-19
11.04%
>
Products
Total 10
ProductsTransactionsPerDetail
hum 6897.14%>
pharm 6897.14%>
cod 6897.14%>
e 30 6897.14%>
tempera 6897.14%>
+View All
Hscode rank
Total 10
HSCode NameTransactionsPerDetail
HS 3004905172.86%>
HS 8419111022.86%>
Trading Area
Total 5
AreaTransactionsPerDetail
other2728.12%>
costa rica2323.96%>
italy1818.75%>
india33.12%>
colombia11.04%>
Port statistics
Total 4
Port NameTransactionsPerDetail
newark nj3435.42%>
new york ny1212.5%>
new york1010.42%>
chicago o hare int l11.04%>
shire human genetic therapies ltd. is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as hum,pharm,cod.
According to the 52wmb.com global trade database, as of 2022-07-18, the company has completed 146 international trades,
with its main trading regions covering other,costa rica,italy etc.
The core products include HS300490,HS84191110 etc,
often transported via newark nj,port new york ny, port new york etc,
and its main trading partners are takeda pharma international ireland branch,sartorius stedim,valiant communication ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shire human genetic therapies ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.